טוען...
Pharmacogenomics of Multiple Sclerosis: A Systematic Review
Background: Over the past two decades, various novel disease-modifying drugs for multiple sclerosis (MS) have been approved. However, there is high variability in the patient response to the available medications, which is hypothesized to be partly attributed to genetics. Objectives: To conduct a sy...
שמור ב:
| הוצא לאור ב: | Front Neurol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6399303/ https://ncbi.nlm.nih.gov/pubmed/30863357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2019.00134 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|